Legato Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-44,218
Closed -$1.22M 617
2023
Q4
$1.22M Hold
44,218
0.16% 214
2023
Q3
$987K Sell
44,218
-2,095
-5% -$53.9K 0.14% 245
2023
Q2
$1.18M Buy
46,313
+12,352
+36% +$299K 0.16% 212
2023
Q1
$757K Buy
33,961
+8,297
+32% +$201K 0.14% 254
2022
Q4
$609K Buy
+25,664
New +$596K 0.12% 287

Other funds holding VCYT

Legato Capital Management's VCYT Position: Q1 2024 in Review

Legato Capital Management sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 44,218 shares — an estimated $1.22M sold.

Legato Capital Management first reported a position in VCYT in Q4 2022 and held it in 5 quarters. The position peaked at $1.22M in Q4 2023. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

  • Legato Capital Management reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
  • Legato Capital Management sold 44,218 Veracyte shares in Q1 2024, an estimated $1.22M.
  • Legato Capital Management first reported a position in Veracyte in Q4 2022 and held it in 5 quarters.
  • Legato Capital Management's Veracyte position peaked at $1.22M in Q4 2023.
  • 246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Legato Capital Management's 13F filing for Q1 2024, filed 15 Apr 2024.